Works matching AU Ishizawa, Kenichi


Results: 149
    1
    2
    3
    4
    5
    6

    Outcomes of adult patients with early T-cell precursor (ETP) acute lymphoblastic leukemia/lymphoma (ALL) and non-ETP T-ALL.

    Published in:
    International Journal of Hematology, 2023, v. 117, n. 5, p. 738, doi. 10.1007/s12185-023-03546-6
    By:
    • Onishi, Yasushi;
    • Furukawa, Eijiro;
    • Kamata, Mayumi;
    • Fukatsu, Masahiko;
    • Kameoka, Yoshihiro;
    • Hatta, Shunsuke;
    • Hamada, Hiroyuki;
    • Oyake, Tatsuo;
    • Kai, Tatsuyuki;
    • Sukegawa, Masumi;
    • Nakajima, Shinji;
    • Yanagiya, Ryo;
    • Yamaguchi, Kohei;
    • Takahashi, Taro;
    • Harazaki, Yoriko;
    • Izumi, Toru;
    • Murai, Kazunori;
    • Ito, Shigeki;
    • Ikezoe, Takayuki;
    • Ishizawa, Kenichi
    Publication type:
    Article
    7

    Validation of the iATL-PI prognostic index in therapeutic decision-making for patients with smoldering and chronic ATL: a multicenter study.

    Published in:
    International Journal of Hematology, 2023, v. 117, n. 2, p. 206, doi. 10.1007/s12185-022-03473-y
    By:
    • Imaizumi, Yoshitaka;
    • Iwanaga, Masako;
    • Nosaka, Kisato;
    • Ishitsuka, Kenji;
    • Ishizawa, Kenichi;
    • Ito, Shigeki;
    • Amano, Masahiro;
    • Ishida, Takashi;
    • Uike, Naokuni;
    • Utsunomiya, Atae;
    • Ohshima, Koichi;
    • Tanaka, Junji;
    • Tokura, Yoshiki;
    • Tobinai, Kensei;
    • Watanabe, Toshiki;
    • Uchimaru, Kaoru;
    • Tsukasaki, Kunihiro
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Evaluation of the safety and efficacy of recombinant soluble thrombomodulin for patients with disseminated intravascular coagulation associated with acute leukemia: multicenter prospective study by the Tohoku Hematology Forum.

    Published in:
    2017
    By:
    • Yokoyama, Hisayuki;
    • Takahashi, Naoto;
    • Katsuoka, Yuna;
    • Inomata, Mitsue;
    • Ito, Toshihiro;
    • Meguro, Kuniaki;
    • Kameoka, Yoshihiro;
    • Tsumanuma, Riko;
    • Murai, Kazunori;
    • Noji, Hideyoshi;
    • Ishizawa, Kenichi;
    • Ito, Shigeki;
    • Onishi, Yasushi;
    • Harigae, Hideo;
    • Tohoku Hematology Forum
    Publication type:
    journal article
    18

    Bendamustine plus rituximab for previously untreated patients with indolent B-cell non-Hodgkin lymphoma or mantle cell lymphoma: a multicenter Phase II clinical trial in Japan.

    Published in:
    2017
    By:
    • Ogura, Michinori;
    • Ishizawa, Kenichi;
    • Maruyama, Dai;
    • Uike, Naokuni;
    • Ando, Kiyoshi;
    • Izutsu, Koji;
    • Terui, Yasuhito;
    • Imaizumi, Yoshitaka;
    • Tsukasaki, Kunihiro;
    • Suzuki, Kenshi;
    • Izumi, Tohru;
    • Usuki, Kensuke;
    • Kinoshita, Tomohiro;
    • Taniwaki, Masafumi;
    • Uoshima, Nobuhiko;
    • Suzumiya, Junji;
    • Kurosawa, Mitsutoshi;
    • Nagai, Hirokazu;
    • Uchida, Toshiki;
    • Fukuhara, Noriko
    Publication type:
    journal article
    19
    20
    21
    22
    23

    Safety and feasibility of high-dose ranimustine (MCNU), carboplatin, etoposide, and cyclophosphamide (MCVC) therapy followed by autologous stem cell transplantation for malignant lymphoma.

    Published in:
    International Journal of Hematology, 2012, v. 96, n. 5, p. 624, doi. 10.1007/s12185-012-1186-7
    By:
    • Kameoka, Yoshihiro;
    • Takahashi, Naoto;
    • Ishizawa, Kenichi;
    • Kato, Yuichi;
    • Ito, Jugo;
    • Sasaki, Osamu;
    • Murai, Kazunori;
    • Noji, Hideyoshi;
    • Hirokawa, Makoto;
    • Tajima, Katsusi;
    • Shichishima, Tsutomu;
    • Ishida, Yoji;
    • Harigae, Hideo;
    • Sawada, Kenichi
    Publication type:
    Article
    24

    Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia: a retrospective safety analysis.

    Published in:
    2011
    By:
    • Kobayashi, Yukio;
    • Sakamaki, Hisashi;
    • Fujisawa, Shin;
    • Ando, Kiyoshi;
    • Yamamoto, Kazuhito;
    • Okada, Masaya;
    • Ishizawa, Kenichi;
    • Nagai, Tadashi;
    • Miyawaki, Syuichi;
    • Motoji, Toshiko;
    • Usui, Noriko;
    • Iida, Shinsuke;
    • Taniwaki, Masafumi;
    • Uoshima, Nobuhiko;
    • Seriu, Taku;
    • Ohno, Ryuzo
    Publication type:
    journal article
    25
    26
    27
    28
    29
    30
    31
    33
    34

    Characterization of pendrin in urinary extracellular vesicles in a rat model of aldosterone excess and in human primary aldosteronism.

    Published in:
    Hypertension Research, 2021, v. 44, n. 12, p. 1557, doi. 10.1038/s41440-021-00710-5
    By:
    • Ochiai-Homma, Fumika;
    • Kuribayashi-Okuma, Emiko;
    • Tsurutani, Yuya;
    • Ishizawa, Kenichi;
    • Fujii, Wataru;
    • Odajima, Kohei;
    • Kawagoe, Mika;
    • Tomomitsu, Yoshihiro;
    • Murakawa, Masataka;
    • Asakawa, Shinichiro;
    • Hirohama, Daigoro;
    • Nagura, Michito;
    • Arai, Shigeyuki;
    • Yamazaki, Osamu;
    • Tamura, Yoshifuru;
    • Fujigaki, Yoshihide;
    • Nishikawa, Tetsuo;
    • Shibata, Shigeru
    Publication type:
    Article
    35
    36

    A phase 2 study of polatuzumab vedotin + bendamustine + rituximab in relapsed/refractory diffuse large B‐cell lymphoma.

    Published in:
    Cancer Science, 2021, v. 112, n. 7, p. 2845, doi. 10.1111/cas.14937
    By:
    • Terui, Yasuhito;
    • Rai, Shinya;
    • Izutsu, Koji;
    • Yamaguchi, Motoko;
    • Takizawa, Jun;
    • Kuroda, Junya;
    • Ishikawa, Takayuki;
    • Kato, Koji;
    • Suehiro, Youko;
    • Fukuhara, Noriko;
    • Ohmine, Ken;
    • Goto, Hideki;
    • Yamamoto, Kazuhito;
    • Kanemura, Nobuhiro;
    • Ueda, Yasunori;
    • Ishizawa, Kenichi;
    • Kumagai, Kyoya;
    • Kawasaki, Atsuko;
    • Saito, Tomohisa;
    • Hashizume, Misato
    Publication type:
    Article
    37

    Prognosis of patients with adult T‐cell leukemia/lymphoma in Japan: A nationwide hospital‐based study.

    Published in:
    Cancer Science, 2020, v. 111, n. 12, p. 4567, doi. 10.1111/cas.14658
    By:
    • Imaizumi, Yoshitaka;
    • Iwanaga, Masako;
    • Nosaka, Kisato;
    • Ishitsuka, Kenji;
    • Ishizawa, Kenichi;
    • Ito, Shigeki;
    • Amano, Masahiro;
    • Ishida, Takashi;
    • Uike, Naokuni;
    • Utsunomiya, Atae;
    • Ohshima, Koichi;
    • Tanaka, Junji;
    • Tokura, Yoshiki;
    • Tobinai, Kensei;
    • Watanabe, Toshiki;
    • Uchimaru, Kaoru;
    • Tsukasaki, Kunihiro;
    • Takaori, Akifumi;
    • Hishizawa, Masakatsu;
    • Kitanaka, Akira
    Publication type:
    Article
    38

    Isatuximab monotherapy in relapsed/refractory multiple myeloma: A Japanese, multicenter, phase 1/2, safety and efficacy study.

    Published in:
    Cancer Science, 2020, v. 111, n. 12, p. 4526, doi. 10.1111/cas.14657
    By:
    • Sunami, Kazutaka;
    • Suzuki, Kenshi;
    • Ri, Masaki;
    • Matsumoto, Morio;
    • Shimazaki, Chihiro;
    • Asaoku, Hideki;
    • Shibayama, Hirohiko;
    • Ishizawa, Kenichi;
    • Takamatsu, Hiroyuki;
    • Ikeda, Takashi;
    • Maruyama, Dai;
    • Kaneko, Hitomi;
    • Uchiyama, Michihiro;
    • Kiguchi, Toru;
    • Iyama, Satoshi;
    • Murakami, Hirokazu;
    • Takahashi, Keishiro;
    • Tada, Keisuke;
    • Macé, Sandrine;
    • Guillemin‐Paveau, Hélène
    Publication type:
    Article
    39

    Epidemiological and clinical features of adult T-cell leukemia-lymphoma in Japan, 2010-2011: A nationwide survey.

    Published in:
    Cancer Science, 2017, v. 108, n. 12, p. 2478, doi. 10.1111/cas.13398
    By:
    • Nosaka, Kisato;
    • Iwanaga, Masako;
    • Imaizumi, Yoshitaka;
    • Ishitsuka, Kenji;
    • Ishizawa, Kenichi;
    • Ishida, Yoji;
    • Amano, Masahiro;
    • Ishida, Takashi;
    • Uike, Naokuni;
    • Utsunomiya, Atae;
    • Ohshima, Koichi;
    • Kawai, Kazuhiro;
    • Tanaka, Junji;
    • Tokura, Yoshiki;
    • Tobinai, Kensei;
    • Watanabe, Toshiki;
    • Uchimaru, Kaoru;
    • Tsukasaki, Kunihiro
    Publication type:
    Article
    40

    Lenalidomide and low-dose dexamethasone in Japanese patients with newly diagnosed multiple myeloma: A phase II study.

    Published in:
    Cancer Science, 2016, v. 107, n. 5, p. 653, doi. 10.1111/cas.12916
    By:
    • Suzuki, Kenshi;
    • Shinagawa, Atsushi;
    • Uchida, Toshiki;
    • Taniwaki, Masafumi;
    • Hirata, Hirokazu;
    • Ishizawa, Kenichi;
    • Matsue, Kosei;
    • Ogawa, Yoshiaki;
    • Shimizu, Takayuki;
    • Otsuka, Maki;
    • Matsumoto, Morio;
    • Iida, Shinsuke;
    • Terui, Yasuhito;
    • Matsumura, Itaru;
    • Ikeda, Takashi;
    • Takezako, Naoki;
    • Ogaki, Yumi;
    • Midorikawa, Shuichi;
    • Houck, Vanessa;
    • Ervin‐Haynes, Annette
    Publication type:
    Article
    41

    Prognostic biomarkers in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy.

    Published in:
    Cancer Science, 2014, v. 105, n. 11, p. 1435, doi. 10.1111/cas.12526
    By:
    • Yamaguchi, Motoko;
    • Takata, Katsuyoshi;
    • Yoshino, Tadashi;
    • Ishizuka, Naoki;
    • Oguchi, Masahiko;
    • Kobayashi, Yukio;
    • Isobe, Yasushi;
    • Ishizawa, Kenichi;
    • Kubota, Nobuko;
    • Itoh, Kuniaki;
    • Usui, Noriko;
    • Miyazaki, Kana;
    • Wasada, Izumi;
    • Nakamura, Shigeo;
    • Matsuno, Yoshihiro;
    • Oshimi, Kazuo;
    • Kinoshita, Tomohiro;
    • Tsukasaki, Kunihiro;
    • Tobinai, Kensei
    Publication type:
    Article
    42

    Phase I / II study of brentuximab vedotin in Japanese patients with relapsed or refractory CD30-positive Hodgkin's lymphoma or systemic anaplastic large-cell lymphoma.

    Published in:
    Cancer Science, 2014, v. 105, n. 7, p. 840, doi. 10.1111/cas.12435
    By:
    • Ogura, Michinori;
    • Tobinai, Kensei;
    • Hatake, Kiyohiko;
    • Ishizawa, Kenichi;
    • Uike, Naokuni;
    • Uchida, Toshiki;
    • Suzuki, Tatsuya;
    • Aoki, Tomohiro;
    • Watanabe, Takashi;
    • Maruyama, Dai;
    • Yokoyama, Masahiro;
    • Takubo, Takatoshi;
    • Kagehara, Hideaki;
    • Matsushima, Takafumi
    Publication type:
    Article
    43
    44
    45

    Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.

    Published in:
    Cancer Science, 2010, v. 101, n. 9, p. 2059, doi. 10.1111/j.1349-7006.2010.01635.x
    By:
    • Ohmachi, Ken;
    • Ando, Kiyoshi;
    • Ogura, Michinori;
    • Uchida, Toshiki;
    • Itoh, Kuniaki;
    • Kubota, Nobuko;
    • Ishizawa, Kenichi;
    • Yamamoto, Joji;
    • Watanabe, Takashi;
    • Uike, Naokuni;
    • Choi, Ilseung;
    • Terui, Yasuhito;
    • Usuki, Kensuke;
    • Nagai, Hirokazu;
    • Uoshima, Nobuhiko;
    • Tobinai, Kensei
    Publication type:
    Article
    46
    47
    48

    Japanese phase II study of <sup>90</sup>Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma.

    Published in:
    Cancer Science, 2009, v. 100, n. 1, p. 158, doi. 10.1111/j.1349-7006.2008.00999.x
    By:
    • Tobinai, Kensei;
    • Watanabe, Takashi;
    • Ogura, Michinori;
    • Morishima, Yasuo;
    • Hotta, Tomomitsu;
    • Ishizawa, Kenichi;
    • Itoh, Kuniaki;
    • Okamoto, Shin-ichiro;
    • Taniwaki, Masafumi;
    • Tsukamoto, Norifumi;
    • Okumura, Hirokazu;
    • Terauchi, Takashi;
    • Nawano, Shigeru;
    • Matsusako, Masaki;
    • Matsuno, Yoshihiro;
    • Nakamura, Shigeo;
    • Mori, Shigeo;
    • Ohashi, Yasuo;
    • Hayashi, Masaki;
    • Endo, Keigo
    Publication type:
    Article
    49

    Treatable Subsets in Cancer of Unknown Primary Origin.

    Published in:
    Cancer Science, 2001, v. 92, n. 6, p. 704, doi. 10.1111/j.1349-7006.2001.tb01151.x
    By:
    • Sumi, Hajime;
    • Itoh, Kuniaki;
    • Onozawa, Yusuke;
    • Shigeoka, Yasushi;
    • Kodama, Keiji;
    • Ishizawa, Kenichi;
    • Fujii, Hirofumi;
    • Minami, Hironobu;
    • Igarashi, Tadahiko;
    • Sasaki, Yasutsuna
    Publication type:
    Article
    50